Announcements Trials
Browse Landscape

Phase

Phase 3 5Phase 2 3

Status

Completed 4Unknown 1

Sponsor Class

NETWORK 3NIH 2

Study Type

Interventional 5

Sponsor

Cancer Type

Sarcoma 5

Conditions

Lymphoma 57Lymphoma, Large B-Cell, Diffuse 40Precursor Cell Lymphoblastic Leukemia-Lymphoma 39Lymphoma, Follicular 33Leukemia 30Lymphoma, Non-Hodgkin 28Burkitt Lymphoma 19Hodgkin Disease 18Neuroblastoma 13Lymphoma, Large-Cell, Immunoblastic 12Central Nervous System Neoplasms 12Sarcoma 10Multiple Myeloma 10Lymphoma, Mantle-Cell 10Rhabdomyosarcoma 9Wilms Tumor 7Lymphoma, T-Cell, Peripheral 7Lymphoma, Large-Cell, Anaplastic 7Lymphoma, B-Cell, Marginal Zone 7Oligodendroglioma 6Neuroectodermal Tumors, Primitive, Peripheral 5Neoplasms, Plasma Cell 5Neoplasms 5Malignant mesenchymal tumor 5Leukemia, Lymphocytic, Chronic, B-Cell 5Brain Neoplasms 5Astrocytoma 5Retinoblastoma 4Recurrence 4Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4

Interventions

Radiotherapy 7Ifosfamide 6Vincristine 5Filgrastim 5Doxorubicin 5Dactinomycin 5Cyclophosphamide 5Etoposide 3sargramostim 2Topotecan 2Granulocyte Colony-Stimulating Factor 2Chemotherapy, Adjuvant 2Carboplatin 2trioctyl phosphine oxide 1indolepropanol phosphate 1etoposide phosphate 1Watchful Waiting 1Vinorelbine 1Radiotherapy, Conformal 1Radiation 1Observation 1Neoadjuvant Therapy 1Irinotecan 1Granulocyte-Macrophage Colony-Stimulating Factor 1Epirubicin 1Brachytherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 3 × Malignant mesenchymal tumor × Vincristine × Clear all
NCT00354744 2020-01-29

High-Dose Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Metastatic Rhabdomyosarcoma or Ectomesenchymoma

Children's Oncology Group

Phase 3 Completed
109 enrolled 12 charts
Sarcoma

Malignant mesenchymal tumor, Rhabdomyosarcoma, Sarcoma

NCT00002995 2014-02-14

Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma

Children's Oncology Group

Phase 3 Completed
483 enrolled
Sarcoma

Malignant mesenchymal tumor, Rhabdomyosarcoma, Sarcoma

NCT00002898 2013-12-04

Surgery Followed by Chemotherapy in Treating Young Patients With Soft Tissue Sarcoma

National Cancer Institute (NCI)

Phase 3 Completed
400 enrolled
Sarcoma

Malignant mesenchymal tumor, Hemangiopericytoma, Malignant, Fibrosarcoma, Hemangiosarcoma, Liposarcoma, Sarcoma, Neuroectodermal Tumors, Primitive, Peripheral, Desmoplastic Small Round Cell Tumor

NCT00379457 2013-08-12

Combination Chemotherapy in Treating Young Patients With Nonmetastatic Rhabdomyosarcoma

National Cancer Institute (NCI)

Phase 3 Unknown
600 enrolled
Sarcoma

Malignant mesenchymal tumor, Sarcoma

NCT00003958 2013-06-17

Combination Chemotherapy in Treating Patients With Previously Untreated Rhabdomyosarcoma

Children's Oncology Group

Phase 3 Completed
702 enrolled
Sarcoma

Malignant mesenchymal tumor, Rhabdomyosarcoma, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡